Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “nicotine” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 97
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 97 pipeline programs matching "nicotine" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

97 results for “nicotine” Back to intelligence hub

Search results

Page 4 of 5
  1. nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    approved small molecule completed

    2 trials
  2. sublingual nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    1 trial
  3. transdermal nicotine replacement therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    approved small molecule active

    1 trial
  4. Belsomra

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule active

    1 trial
  5. Intravenous Nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule completed

    1 trial
  6. Low strength nicotine e-liquid

    BRIGHT MINDS BIOSCIENCES INC.

    Electronic Cigarette Use

    small molecule terminated

    1 trial
  7. Mailed nicotine replacement therapy (NRT)

    The University of Hong Kong

    Smoking Cessation

    small molecule active

    1 trial
  8. Nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    small molecule completed

    1 trial
  9. Nicotine Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Major Depressive Disorder

    small molecule active

    1 trial
  10. Nicotine Replacement

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking-Related Carcinoma

    small molecule active

    2 trials
  11. Nicotine Replacement Therapy (Habitrol)

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule completed

    1 trial
  12. Nicotine Replacement Treatment (NRT)

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    small molecule completed

    1 trial
  13. Nicotine Replacement therapy

    The University of Hong Kong

    Smoking

    small molecule active

    1 trial
  14. Nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use

    small molecule completed

    1 trial
  15. Nicotine pod

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    small molecule completed

    1 trial
  16. Nicotine replacement therapy sampling

    United Therapeutics Europe Ltd

    Smoking Cessation

    small molecule completed

    1 trial
  17. Oxytocin

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule completed

    1 trial
  18. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule completed

    2 trials
  19. Reduced Nicotine Content Cigarettes

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    small molecule completed

    2 trials
  20. Tolcapone

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule completed

    1 trial
  21. Transdermal nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    small molecule completed

    1 trial
  22. Very Low Nicotine Cigarette

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use

    small molecule active

    1 trial
  23. Very low nicotine cigarettes

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule completed

    1 trial
  24. active nicotine gum

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.